Cargando…
Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study
Objectives. Mechanisms influencing the course of physical and mental functioning after an atherosclerotic event are unclear. We examined effects of white matter lesion (WML) activity on changes in functioning in patients with symptomatic atherosclerotic disease. Methods. In 486 patients (58 ± 9 year...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195506/ https://www.ncbi.nlm.nih.gov/pubmed/22013526 http://dx.doi.org/10.4061/2011/280630 |
_version_ | 1782214132538277888 |
---|---|
author | Grool, Anne M. van der Graaf, Yolanda Witkamp, Theo D. Vincken, Koen L. Mali, Willem P. T. M. Geerlings, Mirjam I. |
author_facet | Grool, Anne M. van der Graaf, Yolanda Witkamp, Theo D. Vincken, Koen L. Mali, Willem P. T. M. Geerlings, Mirjam I. |
author_sort | Grool, Anne M. |
collection | PubMed |
description | Objectives. Mechanisms influencing the course of physical and mental functioning after an atherosclerotic event are unclear. We examined effects of white matter lesion (WML) activity on changes in functioning in patients with symptomatic atherosclerotic disease. Methods. In 486 patients (58 ± 9 years) of the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study, volumetric WML measurements on 1.5T MRI were performed at baseline and 3.9 ± 0.4 years followup. Functioning was assessed with the modified Short-Form 12 (SF-12) questionnaire. Associations of WML progression with changes in functioning were adjusted for age, sex, and vascular risk factors. Results. Physical functioning (baseline: 44, 10th–90th percentile 29–55) improved, whereas mental functioning (baseline: 51, 10th–90th percentile 32–60) declined during followup. WML progression (highest quartile versus rest) contributed to a stronger decline in mental functioning (B = −1.76, 95% CI −3.11 to −0.42), but did not influence changes in physical functioning. Conclusions. Progression of WML volume contributes to a decline in mental functioning in patients with symptomatic atherosclerotic disease. |
format | Online Article Text |
id | pubmed-3195506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | SAGE-Hindawi Access to Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-31955062011-10-19 Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study Grool, Anne M. van der Graaf, Yolanda Witkamp, Theo D. Vincken, Koen L. Mali, Willem P. T. M. Geerlings, Mirjam I. J Aging Res Research Article Objectives. Mechanisms influencing the course of physical and mental functioning after an atherosclerotic event are unclear. We examined effects of white matter lesion (WML) activity on changes in functioning in patients with symptomatic atherosclerotic disease. Methods. In 486 patients (58 ± 9 years) of the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study, volumetric WML measurements on 1.5T MRI were performed at baseline and 3.9 ± 0.4 years followup. Functioning was assessed with the modified Short-Form 12 (SF-12) questionnaire. Associations of WML progression with changes in functioning were adjusted for age, sex, and vascular risk factors. Results. Physical functioning (baseline: 44, 10th–90th percentile 29–55) improved, whereas mental functioning (baseline: 51, 10th–90th percentile 32–60) declined during followup. WML progression (highest quartile versus rest) contributed to a stronger decline in mental functioning (B = −1.76, 95% CI −3.11 to −0.42), but did not influence changes in physical functioning. Conclusions. Progression of WML volume contributes to a decline in mental functioning in patients with symptomatic atherosclerotic disease. SAGE-Hindawi Access to Research 2011 2011-10-16 /pmc/articles/PMC3195506/ /pubmed/22013526 http://dx.doi.org/10.4061/2011/280630 Text en Copyright © 2011 Anne M. Grool et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Grool, Anne M. van der Graaf, Yolanda Witkamp, Theo D. Vincken, Koen L. Mali, Willem P. T. M. Geerlings, Mirjam I. Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study |
title | Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study |
title_full | Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study |
title_fullStr | Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study |
title_full_unstemmed | Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study |
title_short | Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study |
title_sort | progression of white matter lesion volume and health-related quality of life in patients with symptomatic atherosclerotic disease: the smart-mr study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195506/ https://www.ncbi.nlm.nih.gov/pubmed/22013526 http://dx.doi.org/10.4061/2011/280630 |
work_keys_str_mv | AT groolannem progressionofwhitematterlesionvolumeandhealthrelatedqualityoflifeinpatientswithsymptomaticatheroscleroticdiseasethesmartmrstudy AT vandergraafyolanda progressionofwhitematterlesionvolumeandhealthrelatedqualityoflifeinpatientswithsymptomaticatheroscleroticdiseasethesmartmrstudy AT witkamptheod progressionofwhitematterlesionvolumeandhealthrelatedqualityoflifeinpatientswithsymptomaticatheroscleroticdiseasethesmartmrstudy AT vinckenkoenl progressionofwhitematterlesionvolumeandhealthrelatedqualityoflifeinpatientswithsymptomaticatheroscleroticdiseasethesmartmrstudy AT maliwillemptm progressionofwhitematterlesionvolumeandhealthrelatedqualityoflifeinpatientswithsymptomaticatheroscleroticdiseasethesmartmrstudy AT geerlingsmirjami progressionofwhitematterlesionvolumeandhealthrelatedqualityoflifeinpatientswithsymptomaticatheroscleroticdiseasethesmartmrstudy |